journal article·2022Open access

Graphene oxide activates B cells with upregulation of granzyme B expression: evidence at the single-cell level for its immune-modulatory properties and anticancer activity

Marco Orecchioni, Laura Fusco, Raghvendra Mall, Valentina Bordoni, Claudia Fuoco, Darawan Rinchai, Shi Guo, Raquel Sainz, Martina Zoccheddu, Cansu Gurcan, Acelya Yilmazer, Barbara Zavan, Cécilia Ménard-Moyon, Alberto Bianco, Wouter Hendrickx, Davide Bedognetti, Lucia Gemma Delogu

Nanoscale· Volume 14· Issue 2

Abstract

We recently found by single-cell mass cytometry that ex vivo human B cells internalize graphene oxide (GO). The functional impact of such uptake on B cells remains unexplored. Here, we disclosed the effects of GO and amino-functionalized GO (GONH2) interacting with human B cells in vitro and ex vivo at the protein and gene expression levels. Moreover, our study considered three different subpopulations of B cells and their functionality in terms of: (i) cytokine production, (ii) activation markers, (iii) killing activity towards cancer cells. Single-cell mass cytometry screening revealed the higher impact of GO on cell viability towards naïve, memory, and plasma B cell subsets. Different cytokines such as granzyme B (GrB) and activation markers, like CD69, CD80, CD138, and CD38, were differently regulated by GONH2 compared to GO, supporting possible diverse B cell activation paths. Moreover, co-culture experiments also suggest the functional ability of both GOs to activate B cells and therefore enhance the toxicity towards HeLa cancer cell line. Complete transcriptomic analysis on a B cell line highlighted the distinctive GO and GONH2 elicited responses, inducing pathways such as B cell receptor and CD40 signaling pathways, key players for GrB secretion. B cells were regularly left behind the scenes in graphene biological studies; our results may open new horizons in the development of GO-based immune-modulatory strategies having B cell as main actors.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Pharmacy University of Sassari, Sassari, Italy

Department of Immunology, Cancer Program, Sidra Medicine, Education City, Doha, Qatar

Department of Biomedical Sciences, University of Padua, Padua, Italy

Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste, Italy

Qatar Computing Research Institute (QCRI) Hamad Bin Khalifa University (HBKU), Doha, Qatar

Department of Biology, University of Rome Tor Vergata, Rome, Italy

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, ISIS, 67000 Strasbourg, France

Department of Biomedical Engineering, Faculty of Engineering, Ankara University, Ankara, Turkey

Department of Medical Sciences, University of Ferrara, Ferrara, Italy

College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar

Dipartimento di Medicina Interna e Specialità Mediche, Università degli Studi di Genova, Genova, Italy

Funding

Horizon 2020 Framework Programme · Agence Nationale de la Recherche

References (59)

Show source-provided references
1. Brumfiel · Nature · 2009 · 458 · 39010.1038/458390a ↗
2. Geim · Nat. Mater. · 2007 · 6 · 18310.1038/nmat1849 ↗
3. Geim · Science · 2009 · 324 · 153010.1126/science.1158877 ↗
4. Weiss · ACS Nano · 2020 · 14 · 638310.1021/acsnano.0c03697 ↗
5. Mukherjee · Front. Immunol. · 2017 · 8 · 67310.3389/fimmu.2017.00673 ↗
6. Fusco · Theranostics · 2020 · 10 · 543510.7150/thno.40068 ↗
7. Gazzi · Front. Bioeng. Biotechnol. · 2019 · 7 · 29510.3389/fbioe.2019.00295 ↗
8. Keshavan · Cell Death Dis. · 2019 · 10 · 56910.1038/s41419-019-1806-8 ↗
9. Fusco · J. Phys. Mater. · 2020 · 3 · 03400910.1088/2515-7639/ab9317 ↗
10. Rock · J. Exp. Med. · 1984 · 160 · 110210.1084/jem.160.4.1102 ↗
11. Jin · J. Immunol. · 2004 · 173 · 65710.4049/jimmunol.173.1.657 ↗
12. Xu · Eur. J. Immunol. · 2014 · 44 · 27510.1002/eji.201343711 ↗
13. Hagn · J. Immunol. · 2009 · 183 · 183810.4049/jimmunol.0901066 ↗
14. Hagn · OncoImmunology · 2012 · 1 · 136810.4161/onci.22354 ↗
15. Russier · Nanoscale · 2013 · 5 · 1123410.1039/c3nr03543c ↗
16. Orecchioni · Adv. Healthcare Mater. · 2016 · 5 · 27610.1002/adhm.201500606 ↗
17. Fadeel · ACS Nano · 2018 · 12 · 1058210.1021/acsnano.8b04758 ↗
18. Orecchioni · Adv. Drug Delivery Rev. · 2016 · 105 · 16310.1016/j.addr.2016.05.014 ↗
19. Xu · J. Nanosci. Nanotechnol. · 2016 · 16 · 420510.1166/jnn.2016.11712 ↗
20. Murera · Nanoscale · 2019 · 11 · 1049310.1039/C9NR00846B ↗
21. M.Orecchioni , V.Bordoni , C.Fuoco , G.Reina , H.Lin , M.Zoccheddu , A.Yilmazer , B.Zavan , G.Cesareni , D.Bedognetti , A.Bianco and L. G.Delogu , Small , 2020
22. Orecchioni · Nat. Commun. · 2017 · 8 · 110910.1038/s41467-017-01015-3 ↗
23. Reina · ACS Appl. Mater. Interfaces · 2019 · 11 · 769510.1021/acsami.8b18304 ↗
24. Russier · Angew. Chem., Int. Ed. · 2017 · 56 · 301410.1002/anie.201700078 ↗
25. Gurunathan · Int. J. Mol. Sci. · 2019 · 20 · 24710.3390/ijms20020247 ↗
26. Bordoni · Nanoscale · 2019 · 11 · 1940810.1039/C9NR03975A ↗
27. Luo · Ecotoxicol. Environ. Saf. · 2020 · 199 · 11071410.1016/j.ecoenv.2020.110714 ↗
28. Mukherjee · Sci. Rep. · 2018 · 8 · 111510.1038/s41598-018-19521-9 ↗
29. Cooper · Nat. Rev. Immunol. · 2015 · 15 · 19110.1038/nri3801 ↗
30. Vacchi · Nanoscale · 2016 · 8 · 1371410.1039/C6NR03846H ↗
31. Hadjidemetriou · Nat. Nanotechnol. · 2017 · 12 · 28810.1038/nnano.2017.61 ↗
32. Monopoli · J. Am. Chem. Soc. · 2011 · 133 · 252510.1021/ja107583h ↗
33. Wurster · J. Biol. Chem. · 2002 · 277 · 2716910.1074/jbc.M201207200 ↗
34. Unal · Nano Today · 2021 · 38 · 10113610.1016/j.nantod.2021.101136 ↗
35. Amir · Nat. Biotechnol. · 2013 · 31 · 54510.1038/nbt.2594 ↗
36. Bonder · Immunology · 1999 · 96 · 52910.1046/j.1365-2567.1999.00711.x ↗
37. Voskoboinik · Nat. Rev. Immunol. · 2015 · 15 · 38810.1038/nri3839 ↗
38. Kelly · J. Biol. Chem. · 2004 · 279 · 2223610.1074/jbc.M401670200 ↗
39. Hagn · Immunol. Cell Biol. · 2012 · 90 · 45710.1038/icb.2011.64 ↗
40. Leandro · Arthritis Res. Ther. · 2013 · 15 · S310.1186/ar3908 ↗
41. Jones · Pharm. Res. · 1995 · 12 · 205710.1023/A:1016285132282 ↗
42. Sahoo · Scand. J. Immunol. · 2002 · 55 · 57710.1046/j.1365-3083.2002.01093.x ↗
43. McCarron · Blood · 2017 · 129 · 274910.1182/blood-2017-01-761643 ↗
44. Roelands · Emerging Top. Life Sci. · 2017 · 1 · 42910.1042/ETLS20170142 ↗
45. Dorner · Immunology · 2009 · 128 · 57310.1111/j.1365-2567.2009.03143.x ↗
46. Browne · Immunology · 2012 · 136 · 37010.1111/j.1365-2567.2012.03587.x ↗
47. Kamburov · Nucleic Acids Res. · 2013 · 41 · D79310.1093/nar/gks1055 ↗
48. Mukherjee · PLoS One · 2016 · 11 · e016681610.1371/journal.pone.0166816 ↗
49. Bendall · Science · 2011 · 332 · 68710.1126/science.1198704 ↗
50. Du · Bioinformatics · 2008 · 24 · 154710.1093/bioinformatics/btn224 ↗
51. Ritchie · Nucleic Acids Res. · 2015 · 43 · e4710.1093/nar/gkv007 ↗
52. C.Martin , Encyclopedia of Systems Biology , 2013
53. Herwig · Nat. Protoc. · 2016 · 11 · 188910.1038/nprot.2016.117 ↗
54. Kanehisa · Nucleic Acids Res. · 2017 · 45 · D35310.1093/nar/gkw1092 ↗
55. Nishimura · Bio. Soft. Internet Rep. · 2001 · 2 · 11710.1089/152791601750294344 ↗
56. Fabregat · BMC Bioinf. · 2017 · 18 · 14210.1186/s12859-017-1559-2 ↗
57. Slenter · Nucleic Acids Res. · 2018 · 46 · D66110.1093/nar/gkx1064 ↗
58. Huang da · Nat. Protoc. · 2009 · 4 · 4410.1038/nprot.2008.211 ↗
59. Blondel · J. Stat. Mech.: Theory Exp. · 2008 · 10 · P1000810.1088/1742-5468/2008/10/P10008 ↗